HELP Study - Towards High Throughput and Efficient Long-axial PET With Oral [18F]FDG
Recruiting
N/A
Interventional Study
Multiple Cancers
Multiple Indications Cancer
Feasibility Studies
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 19 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 27 (estimated)
- Sponsor
- British Columbia Cancer Agency · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Typically, PET scans involve an IV injection of 18F-FDG that helps identify cancer. Patients are scanned 60 minutes after injecting 18F-FDG. This study aims to assess the feasibility of a different method of administration - oral ingestion (rather than IV) of 18F-FDG through delayed imaging to identify the optimal time for scanning after consuming the drug. The study will aim to recruit 15-24 indi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥19 years
* Participants who have received a standard of care \[18F\]FDG PET/CT and are willing to undergo a study specific oral \[18F\]FDG PET/CT within 2 weeks.
Exclusion Criteria:
Participant Inclusion Criteria
* Age ≥19 years
* Participants who have received a stand…
Contacts